Violation Tracker Individual Record

Company: 
TAP Pharmaceutical Products, Inc.
Current Parent Company: 
Takeda Pharmaceutical
Penalty: 
$798,000
Year: 
2006
Date: 
May 25, 2006
Offense Group: 
competition-related offenses
Primary Offense: 
kickbacks and bribery
Violation Description: 

TAP Pharmaceutical Products agreed to pay $798,000 to settle allegations of fraudulent marketing practices which included improperly influencing doctors to prescribe the high-priced cancer drug, Lupron.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Wisconsin Attorney General
Civil or Criminal Case: 
civil
Facility State: 
Wisconsin
HQ Country of Parent: 
Japan
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.